Johnson & Johnson Challenges the Constitutionality of FCA $1.6 Billion Verdict -
Following a record $1.6 billion jury verdict for off-label promotion of HIV drugs Prezista and Intelence, Johnson & Johnson (J&J) subsidiary...more
7/28/2025
/ Anti-Kickback Statute ,
Appeals ,
CARES Act ,
Constitutional Challenges ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
Economic Injury Disaster Loans ,
False Claims Act (FCA) ,
First Amendment ,
Jury Verdicts ,
Paycheck Protection Program (PPP) ,
Penalties ,
Pharmaceutical Industry ,
Prescription Drugs ,
Scienter ,
Tax Fraud ,
Whistleblowers
Federal Court Imposes Nearly $1 Billion in FCA Damages and Penalties Against Omnicare and CVS -
On July 7, Southern District of New York District Judge Colleen McMahon increased a False Claims Act (FCA) judgment from $136...more
7/14/2025
/ CVS ,
Damages ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
Investigations ,
Medicare ,
Penalties ,
Pharmaceutical Industry ,
Pharmacies ,
Popular ,
Prescription Drugs ,
Securities and Exchange Commission (SEC) ,
Settlement
Gilead to Pay $202 Million to Settle DOJ Claims Over Speaker Program Kickbacks -
Gilead Sciences, Inc. has agreed to pay $202 million to resolve allegations brought by the US Department of Justice (DOJ) that it violated...more
Walgreens to Pay $300 Million to Settle DOJ Claims Over Invalid Opioid Prescriptions -
Walgreens Boots Alliance has agreed to pay more than $300 million to resolve allegations brought by the US Department of Justice (DOJ)...more
4/28/2025
/ Anti-Kickback Statute ,
Causation ,
Controlled Substances ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud ,
Healthcare Fraud ,
Opioid ,
Pharmaceutical Industry ,
Pharmacies ,
Settlement ,
Whistleblowers